Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2020

01-12-2020 | Coronavirus | Research article

Mapping the situation of research on coronavirus disease-19 (COVID-19): a preliminary bibliometric analysis during the early stage of the outbreak

Authors: Sa’ed H. Zyoud, Samah W. Al-Jabi

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

The novel coronavirus, named as 2019-nCoV or coronavirus disease 2019 (COVID-19), has recently appeared in China and has spread worldwide, presenting a health threat to the global community. Therefore, it is important to understand the global scientific output of COVID-19 research during the early stage of the outbreak. Thus, to track the current hotspots, and highlight future directions, we performed a bibliometric analysis to obtain an approximate scenario of COVID-19 to date.

Methods

Relevant studies to COVID-19 were obtained from the Scopus database during the early stage of the outbreak. We then analysed the data by using well-established bibliometric indices: document type, country, collaboration patterns, affiliation, journal name, and citation patterns. VOSviewer was applied to map and determine hot topics in this field.

Results

The bibliometric analysis indicated that there were 19,044 publications on Scopus published on COVID-19 during the early stage of the outbreak (December 2019 up until June 19, 2020). Of all these publications, 9140 (48.0%) were articles; 4192 (22.0%) were letters; 1797 (9.4%) were reviews; 1754 (9.2%) were editorials; 1728 (9.1%) were notes; and 433 (2.3%) were others. The USA published the largest number of publications on COVID-19 (4479; 23.4%), followed by China (3310; 17.4%), Italy, (2314; 12.2%), and the UK (1981; 10.4%). British Medical Journal was the most productive. The Huazhong University of Science and Technology, Tongji Medical, and Harvard Medical School were the institutions that published the largest number of COVID-19 research. The most prevalent topics of research in COVID-19 include “clinical features studies”, “pathological findings and therapeutic design”, “care facilities preparation and infection control”, and “maternal, perinatal and neonatal outcomes”.

Conclusions

This bibliometric study may reflect rapidly emerging topics on COVID-19 research, where substantial research activity has already begun extensively during the early stage of the outbreak. The findings reported here shed new light on the major progress in the near future for hot topics on COVID-19 research including clinical features studies, pathological findings and therapeutic design, care facilities preparation and infection control, and maternal, perinatal and neonatal outcomes.
Literature
1.
Pung R, Chiew CJ, Young BE, Chin S, Chen MI, Clapham HE, Cook AR, Maurer-Stroh S, Toh M, Poh C, et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet. 2020;395(10229):1039–46.PubMedPubMedCentralCrossRef
2.
Wu Y, Ho W, Huang Y, Jin DY, Li S, Liu SL, Liu X, Qiu J, Sang Y, Wang Q, et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet. 2020;395(10228):949–50.PubMedPubMedCentralCrossRef
3.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.PubMedPubMedCentralCrossRef
4.
Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425–34.PubMedPubMedCentralCrossRef
5.
6.
7.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.PubMedPubMedCentralCrossRef
8.
Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, Sun C, Sylvia S, Rozelle S, Raat H, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9(1):29.PubMedPubMedCentralCrossRef
9.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9.PubMedCentralCrossRefPubMed
10.
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11.PubMedPubMedCentral
11.
12.
Gisbert JP, Panes J. Scientific publication, bibliometric indicators, and Hirsch's h-index. Gastroenterol Hepatol. 2009;32(3):140–9.PubMedCrossRef
13.
Wallin JA. Bibliometric methods: pitfalls and possibilities. Basic Clin Pharmacol Toxicol. 2005;97(5):261–75.PubMedCrossRef
14.
15.
Al-Jabi SW. Global research trends in West Nile virus from 1943 to 2016: a bibliometric analysis. Glob Health. 2017;13(1):55.CrossRef
16.
Hagel C, Weidemann F, Gauch S, Edwards S, Tinnemann P. Analysing published global Ebola virus disease research using social network analysis. PLoS Negl Trop Dis. 2017;11(10):e0005747.PubMedPubMedCentralCrossRef
17.
Sweileh WM. Bibliometric analysis of literature in AIDS-related stigma and discrimination. Transl Behav Med. 2019;9(4):617–28.PubMedCrossRef
18.
Zou Y, Luo Y, Zhang J, Xia N, Tan G, Huang C. Bibliometric analysis of oncolytic virus research, 2000 to 2018. Medicine (Baltimore). 2019;98(35):e16817.CrossRef
19.
Culquichicon C, Cardona-Ospina JA, Patino-Barbosa AM, Rodriguez-Morales AJ. Bibliometric analysis of Oropouche research: impact on the surveillance of emerging arboviruses in Latin America. F1000Res. 2017;6:194.PubMedPubMedCentralCrossRef
20.
Pereira-Silva JW. Bibliometric assessment of scientific production of literature of West Nile virus. J Infect Public Health. 2017;10(3):363–5.PubMedCrossRef
21.
Albuquerque PC, Castro MJ, Santos-Gandelman J, Oliveira AC, Peralta JM, Rodrigues ML. Bibliometric indicators of the Zika outbreak. PLoS Negl Trop Dis. 2017;11(1):e0005132.PubMedPubMedCentralCrossRef
22.
Rios-Gonzalez CM. Bibliometric study of international scientific production in O'nyong-nyong virus during the years 1962-2016. J Infect Public Health. 2017;10(1):137–8.PubMedCrossRef
23.
Garg KC, Kumar S. Bibliometrics of global Ebola virus disease research as seen through science citation index expanded during 1987-2015. Travel Med Infect Dis. 2017;16:64–5.PubMedCrossRef
24.
25.
Del Carpio OL. Guillain-Barre syndrome associated with zika virus infection in the Americas: a bibliometric study. Neurologia. 2020;35(6):426–9.
26.
27.
Rios-Gonzalez CM, Veron Mellid FG. When has it been studied about La Crosse virus?: Bibliometric analysis of world scientific production. J Infect Public Health. 2018;11(5):745–6.PubMedCrossRef
28.
Andersen JP, Nielsen MW, Simone NL, Lewiss RE, Jagsi R. COVID-19 medical papers have fewer women first authors than expected. Elife. 2020;9:e58807.
29.
Chahrour M, Assi S, Bejjani M, Nasrallah AA, Salhab H, Fares M, Khachfe HH. A Bibliometric analysis of COVID-19 research activity: a call for increased output. Cureus. 2020;12(3):e7357.PubMedPubMedCentral
30.
Haghani M, Bliemer MCJ, Goerlandt F, Li J. The scientific literature on coronaviruses, COVID-19 and its associated safety-related research dimensions: a scientometric analysis and scoping review. Saf Sci. 2020;129:104806.PubMedCentralCrossRefPubMed
31.
Kambhampati SBS, Vaishya R, Vaish A. Unprecedented surge in publications related to COVID-19 in the first three months of pandemic: a bibliometric analytic report. J Clin Orthop Trauma. 2020;11(Suppl 3):S304–6.PubMedCentralCrossRefPubMed
32.
Lou J, Tian SJ, Niu SM, Kang XQ, Lian HX, Zhang LX, Zhang JJ. Coronavirus disease 2019: a bibliometric analysis and review. Eur Rev Med Pharmacol Sci. 2020;24(6):3411–21.PubMed
33.
Mao X, Guo L, Fu P, Xiang C. The status and trends of coronavirus research: a global bibliometric and visualized analysis. Medicine (Baltimore). 2020;99(22):e20137.CrossRef
34.
Tao Z, Zhou S, Yao R, Wen K, Da W, Meng Y, Yang K, Liu H, Tao L. COVID-19 will stimulate a new coronavirus research breakthrough: a 20-year bibliometric analysis. Ann Transl Med. 2020;8(8):528.PubMedPubMedCentralCrossRef
35.
Zhai F, Zhai Y, Cong C, Song T, Xiang R, Feng T, Liang Z, Zeng Y, Yang J, Yang J, et al. Research Progress of Coronavirus Based on Bibliometric Analysis. Int J Environ Res Public Health. 2020;17(11):3766.
36.
Zhou Y, Chen L. Twenty-Year Span of Global Coronavirus Research Trends: A Bibliometric Analysis. Int J Environ Res Public Health. 2020;17(9):3082.
37.
Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. FASEB J. 2008;22(2):338–42.PubMedCrossRef
38.
Kulkarni AV, Aziz B, Shams I, Busse JW. Comparisons of citations in web of science, Scopus, and Google scholar for articles published in general medical journals. JAMA. 2009;302(10):1092–6.PubMedCrossRef
39.
Mongeon P, Paul-Hus A. The journal coverage of web of science and Scopus: a comparative analysis. Scientometrics. 2015;106(1):213–28.CrossRef
40.
Zyoud SH, Smale S, Waring WS, Sweileh WM, Al-Jabi SW. Global research trends in microbiome-gut-brain axis during 2009-2018: a bibliometric and visualized study. BMC Gastroenterol. 2019;19(1):158.PubMedPubMedCentralCrossRef
41.
42.
43.
F DEF. Polimeni a: coronavirus disease (COVID-19): a machine learning Bibliometric analysis. In Vivo. 2020;34(3 Suppl):1613–7.CrossRef
44.
van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–38.PubMedCrossRef
45.
46.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.PubMedCrossRef
47.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.PubMedPubMedCentralCrossRef
48.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.PubMedPubMedCentralCrossRef
49.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–207.PubMedPubMedCentralCrossRef
50.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239–42.
51.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3.PubMedPubMedCentralCrossRef
52.
Chan JF, Yuan S, Kok KH, KK T, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–23.PubMedPubMedCentralCrossRef
53.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74.PubMedPubMedCentralCrossRef
54.
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929–36.PubMedPubMedCentralCrossRef
55.
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–81.PubMedPubMedCentralCrossRef
56.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–71.PubMedPubMedCentralCrossRef
57.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2.PubMedPubMedCentralCrossRef
58.
van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–7.PubMedCrossRef
59.
Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–80 e278.PubMedPubMedCentralCrossRef
60.
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–1.PubMedPubMedCentralCrossRef
61.
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. HLH across Speciality collaboration UK: COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4.PubMedPubMedCentralCrossRef
62.
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177–9.PubMedPubMedCentralCrossRef
63.
Maula AW, Fuad A, Utarini A. Ten-years trend of dengue research in Indonesia and south-east Asian countries: a bibliometric analysis. Glob Health Action. 2018;11(1):1504398.PubMedPubMedCentralCrossRef
64.
Okoroiwu HU, Lopez-Munoz F, Povedano-Montero FJ. Bibliometric analysis of global Lassa fever research (1970-2017): a 47 - year study. BMC Infect Dis. 2018;18(1):639.PubMedPubMedCentralCrossRef
65.
Sweileh WM. Global research trends of World Health Organization's top eight emerging pathogens. Glob Health. 2017;13(1):9.CrossRef
66.
67.
Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, Mechain M, Meurice L, Nguyen M, Bassi C et al: First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020;25(6):2000094.
68.
Marchand-Senecal X, Kozak R, Mubareka S, Salt N, Gubbay JB, Eshaghi A, Allen V, Li Y, Bastien N, Gilmour M, et al. Diagnosis and Management of First Case of COVID-19 in Canada: lessons applied from SARS. Clin Infect Dis. 2020. https://​doi.​org/​10.​1093/​cid/​ciaa227.
69.
Wells CR, Sah P, Moghadas SM, Pandey A, Shoukat A, Wang Y, Wang Z, Meyers LA, Singer BH, Galvani AP. Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak. Proc Natl Acad Sci U S A. 2020;117(13):7504–9.PubMedPubMedCentralCrossRef
70.
Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA. 2020;323(14):1335.
71.
Spiteri G, Fielding J, Diercke M, Campese C, Enouf V, Gaymard A, Bella A, Sognamiglio P, Sierra Moros MJ, Riutort AN, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European region, 24 January to 21 February 2020. Euro Surveill. 2020;25(9):2000178.
72.
Kiraz M, Demir E. A Bibliometric analysis of publications on spinal cord injury during 1980-2018. World Neurosurg. 2020;136:e504–13.PubMedCrossRef
73.
74.
Hernandez-Vasquez A, Alarcon-Ruiz CA, Bendezu-Quispe G, Comande D, Rosselli D. A bibliometric analysis of the global research on biosimilars. J Pharm Policy Pract. 2018;11:6.PubMedPubMedCentralCrossRef
75.
Khalili M, Rahimi-Movaghar A, Shadloo B, Mojtabai R, Mann K, Amin-Esmaeili M. Global scientific production on illicit drug addiction: a two-decade analysis. Eur Addict Res. 2018;24(2):60–70.PubMedCrossRef
76.
Lee RP, Xu R, Dave P, Ajmera S, Lillard JC, Wallace D, Broussard A, Motiwala M, Norrdahl S, Howie C, et al. Taking the next step in publication productivity analysis in pediatric neurosurgery. J Neurosurg Pediatr. 2018;21(6):655–65.PubMedCrossRef
77.
78.
Teles RHG, Moralles HF, Cominetti MR. Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis. Int J Nanomedicine. 2018;13:2321–36.PubMedPubMedCentralCrossRef
79.
Yao H, Wan JY, Wang CZ, Li L, Wang J, Li Y, Huang WH, Zeng J, Wang Q, Yuan CS. Bibliometric analysis of research on the role of intestinal microbiota in obesity. PeerJ. 2018;6:e5091.PubMedPubMedCentralCrossRef
80.
Zyoud SH. Investigating global trends in paraquat intoxication research from 1962 to 2015 using bibliometric analysis. Am J Ind Med. 2018;61(6):462–70.PubMedCrossRef
81.
Agarwal A, Durairajanayagam D, Tatagari S, Esteves SC, Harlev A, Henkel R, Roychoudhury S, Homa S, Puchalt NG, Ramasamy R, et al. Bibliometrics: tracking research impact by selecting the appropriate metrics. Asian J Androl. 2016;18(2):296–309.PubMedPubMedCentralCrossRef
Metadata
Title
Mapping the situation of research on coronavirus disease-19 (COVID-19): a preliminary bibliometric analysis during the early stage of the outbreak
Authors
Sa’ed H. Zyoud
Samah W. Al-Jabi
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05293-z

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue

Research article

Beyond clinical outcomes: the social and healthcare system implications of hepatitis C treatment

Research article

Serum neopterin levels in relation to mild and severe COVID-19

Research article

Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study

Study protocol

Prevention of post-splenectomy sepsis in patients with asplenia - a study protocol of a controlled trial

Research article

Sepsis in cancer patients residing in Zimbabwe: spectrum of bacterial and fungal aetiologies and their antimicrobial susceptibility patterns

Research article

A blood RNA transcript signature for TB exposure in household contacts
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits